Cargando…
Biomarkers in the Era of Precision Oncology
Autor principal: | Baxevanis, Constantin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046681/ https://www.ncbi.nlm.nih.gov/pubmed/36980668 http://dx.doi.org/10.3390/cancers15061782 |
Ejemplares similares
-
Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015) -
Individualized prognostic calculators in the precision oncology era
por: Taylor, Jeremy M.G., et al.
Publicado: (2019) -
DNA-protein biomarkers for immunotherapy in the era of precision oncology
por: Kim, Binnari, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
por: Baxevanis, Constantin N.
Publicado: (2023) -
Liquid Biopsy: A Biomarker-Driven Tool towards Precision Oncology
por: Yee, Nelson S.
Publicado: (2020)